Lower urinary tract symptoms (LUTS) and bladder afferent activity

Area of Science:

• Urology
• Neuroscience
• Pharmacology

Background:

• Lower urinary tract symptoms (LUTS) and overactive bladder (OAB) arise from dysregulated bladder afferent activity and detrusor muscle function.
• Current LUTS treatments have poor tolerability and significant side effects.

Purpose of the Study:

• To explore novel therapeutic targets for LUTS by examining bladder neuroanatomy and afferent pathway signaling.
• To challenge traditional understanding of antimuscarinic therapy mechanisms.

Main Methods:

• Review of major advances in bladder neuroanatomy and afferent pathway research.
• Analysis of sensory signaling cascades involving urothelial and suburothelial structures.
• Investigation of neurotransmitter and receptor interactions in bladder signal transduction.

Main Results:

• Urothelial and suburothelial structures play a key sensory role in LUTS generation.
• Afferent bladder signaling involves complex interactions between epithelium, detrusor muscle, neurotransmitters, and receptors.
• Muscarinic 2 (M(2)) receptors in the urothelium may influence bladder afferent fibers, altering the understanding of antimuscarinic effects.

Conclusions:

• LUTS etiology includes dysregulated sensory signaling originating from the bladder epithelium and other pelvic structures.
• Understanding these complex signaling pathways offers potential for new LUTS treatments.